Related Experiment Video
Updated: May 9, 2026

Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture
Published on: October 12, 2018
Severe skin rash with lamivudine in HIV infected patients: some unusual case reports
Dolanchampa Modak1, Subhasish Kamal Guha
1Department of Tropical Medicine, School of Tropical Medicine, Kolkata, West Bengal, India.
Abstract:
Lamivudine (3TC) is a nucleoside reverse transcriptase inhibitor (NRTI) licensed for as a first line drug in Human immunodeficiency virus (HIV) infection and also in the treatment of hepatitis B. It is relatively nontoxic in nature and potentiates the antiviral effects of other NRTIs like zidovudine. Although lamivudine is well-tolerated, certain dermatological side effects like severe skin rash may appear. We report a case series of severe skin rashes in four HIV-infected patients, probably due to lamivudine.
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pharmacokinetics in Pediatric Patients: Drug Excretion
Retrovirus Life Cycles
Drug toxicity: Idiosyncratic Reactions
Hypersensitivity Reactions: Immune-Complex Reactions
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...